scholarly article | Q13442814 |
P50 | author | Sheila MacNeil | Q55081121 |
Stephen Rimmer | Q57307106 | ||
C. W. Ian Douglas | Q57313428 | ||
Prashant Garg | Q57313432 | ||
Sanhita Roy | Q89783137 | ||
Nagaveni Shivshetty | Q91098797 | ||
Abigail Pinnock | Q106013377 | ||
P2860 | cites work | Animal use in pharmacology education and research: the changing scenario | Q26861233 |
Role of defensins in corneal epithelial barrier function against Pseudomonas aeruginosa traversal | Q28116404 | ||
LL-37, the only human member of the cathelicidin family of antimicrobial peptides | Q28241675 | ||
Epidemic population structure of Pseudomonas aeruginosa: evidence for a clone that is pathogenic to the eye and that has a distinct combination of virulence factors | Q31082475 | ||
Multipurpose care solution-induced corneal surface disruption and Pseudomonas aeruginosa internalization in the rabbit corneal epithelium | Q33892915 | ||
The collagen-binding adhesin is a virulence factor in Staphylococcus aureus keratitis | Q34004897 | ||
Profile of microbial keratitis after corneal collagen cross-linking | Q34271007 | ||
The molecular pathogenicity of Fusarium keratitis: a fungal transcriptional regulator promotes hyphal penetration of the cornea | Q34348870 | ||
Activation of focal adhesion kinase enhances the adhesion of Fusarium solani to human corneal epithelial cells via the tyrosine-specific protein kinase signaling pathway. | Q34664196 | ||
Factors Impacting Corneal Epithelial Barrier Function againstPseudomonas aeruginosaTraversal | Q35005942 | ||
A Comparison of Clinical Features between Community-Associated and Healthcare-Associated Methicillin-Resistant Staphylococcus aureus Keratitis | Q35012906 | ||
Animal models to investigate fungal biofilm formation | Q35130387 | ||
Assessment of anti-scarring therapies in ex vivo organ cultured rabbit corneas | Q35196233 | ||
Pseudomonas aeruginosa-mediated cytotoxicity and invasion correlate with distinct genotypes at the loci encoding exoenzyme S. | Q35567132 | ||
In vivo confocal microscopy for the detection of canine fungal keratitis and monitoring of therapeutic response | Q35659694 | ||
Human tear fluid protects against Pseudomonas aeruginosa keratitis in a murine experimental model. | Q35784193 | ||
Staphylococcus aureus corneal infections: effect of the Panton-Valentine leukocidin (PVL) and antibody to PVL on virulence and pathology | Q36979233 | ||
Why does the healthy cornea resist Pseudomonas aeruginosa infection? | Q37032684 | ||
The development of a tissue-engineered cornea: biomaterials and culture methods | Q37143932 | ||
The role of twitching motility in Pseudomonas aeruginosa exit from and translocation of corneal epithelial cells | Q37337729 | ||
Pseudomonas aeruginosa LasA protease in treatment of experimental staphylococcal keratitis | Q37733684 | ||
Animal models of bacterial keratitis | Q37832951 | ||
Mycotic keratitis: epidemiology, diagnosis and management | Q38080589 | ||
Staphylococcus aureus-induced corneal inflammation is dependent on Toll-like receptor 2 and myeloid differentiation factor 88 | Q38483194 | ||
Esculentin-1a(1-21)NH2: a frog skin-derived peptide for microbial keratitis | Q39149551 | ||
Development of a microfabricated artificial limbus with micropockets for cell delivery to the cornea. | Q39434091 | ||
Development of a surface-modified contact lens for the transfer of cultured limbal epithelial cells to the cornea for ocular surface diseases | Q39876340 | ||
The corneal response to Pseudomonas aeruginosa: histopathological and enzymatic characterization | Q40039935 | ||
TLR2 activation in corneal stromal cells by Staphylococcus aureus-induced keratitis | Q41685423 | ||
Topical caspofungin for treatment of keratitis caused by Candida albicans in a rabbit model | Q41895249 | ||
Experimental model of Fusarium solani keratitis in rats | Q42142421 | ||
miR-155 suppresses bacterial clearance in Pseudomonas aeruginosa-induced keratitis by targeting Rheb | Q42233667 | ||
Ex vivo organotypic corneal model of acute epithelial herpes simplex virus type I infection | Q42385878 | ||
Rocking media over ex vivo corneas improves this model and allows the study of the effect of proinflammatory cytokines on wound healing | Q42557525 | ||
Topical neutralization of interleukin-17 during experimental Pseudomonas aeruginosa corneal infection promotes bacterial clearance and reduces pathology | Q42682868 | ||
Comparative analysis of agr groups and virulence genes among subclinical and clinical mastitis Staphylococcus aureus isolates from sheep flocks of the Northeast of Brazil | Q42878595 | ||
Effect of Pseudomonas aeruginosa concentration in experimental contact lens-related microbial keratitis. | Q43483868 | ||
Corneal wound healing is modulated by topical application of amniotic fluid in an ex vivo organ culture model | Q43603479 | ||
Antifungal efficacy of voriconazole, itraconazole and amphotericin b in experimental fusarium solani keratitis | Q43631118 | ||
In vivo challenging of polymyxins and levofloxacin eye drop against multidrug-resistant Pseudomonas aeruginosa keratitis. | Q43767005 | ||
Staphylococcus corneal virulence in a new topical model of infection | Q43785472 | ||
Staphylolysin is an effective therapeutic agent for Staphylococcus aureus experimental keratitis | Q43831127 | ||
lukSF-PV in Staphylococcus aureus keratitis isolates and association with clinical outcome | Q44366592 | ||
Development of a novel ex vivo model of corneal fungal adherence | Q45001228 | ||
Epidemiological features and laboratory results of bacterial and fungal keratitis: a five-year study at a rural tertiary-care hospital in western Maharashtra, India. | Q45956190 | ||
Bacterial corneal ulcer treated with intrastromal antibiotic. Experimental model in vivo | Q46064364 | ||
Effectiveness of topical taurolidine versus ciprofloxacin, ofloxacin, and fortified cefazolin in a rabbit Staphylococcus aureus keratitis model | Q46417164 | ||
Fusarium keratitis at a tertiary eye care centre in India | Q46879653 | ||
Triple infection keratitis | Q46912470 | ||
In vivo performance of melimine as an antimicrobial coating for contact lenses in models of CLARE and CLPU. | Q50598883 | ||
Corneal virulence of Candida albicans strains deficient in Tup1-regulated genes. | Q52579391 | ||
Glycan structures of ocular surface mucins in man, rabbit and dog display species differences. | Q53540872 | ||
The Corneal Expression of Antimicrobial Peptides during Experimental Fungal Keratitis | Q54410145 | ||
The use of concanavalin A to competitively inhibit Pseudomonas aeruginosa adherence to rabbit corneal epithelium | Q68346462 | ||
The three-dimensional microanatomy of the rabbit and human cornea. A chemical and mechanical microdissection-SEM approach | Q77400606 | ||
Corneal virulence of Pseudomonas aeruginosa elastase B and alkaline protease produced by Pseudomonas putida | Q80204660 | ||
A Staphylococcus aureus mouse keratitis topical infection model: cytokine balance in different strains of mice | Q81722172 | ||
Type III secretion system-associated toxins, proteases, serotypes, and antibiotic resistance of Pseudomonas aeruginosa isolates associated with keratitis | Q83127282 | ||
Reduce, Refine, Replace | Q85224911 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 2 | |
P1104 | number of pages | 10 | |
P304 | page(s) | 333-342 | |
P577 | publication date | 2016-11-14 | |
P1433 | published in | Graefe's Archive for Clinical and Experimental Ophthalmology | Q15757667 |
P1476 | title | Ex vivo rabbit and human corneas as models for bacterial and fungal keratitis | |
P478 | volume | 255 |
Q93166850 | An ex vivo cornea infection model |
Q49924076 | An ex vivo ruminal ovine model to study the immediate immune response in the context of bacterial lipopolysaccharide |
Q93387957 | Ex vivo Caprine Model to Study Virulence Factors in Keratitis |
Q49679766 | Fungal Biofilms and Polymicrobial Diseases |
Search more.